Importance of schedule in adriamycin/cyclophosphamide combination chemotherapy.
D000818:Animals; D001853:Bone Marrow / Q000378:metabolism; D002452:Cell Count; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004317:Doxorubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice
D004273:DNA, Neoplasm; D004317:Doxorubicin; D003520:Cyclophosphamide